Mice Model Market
Report ID: SQMIG35H2381
Report ID: SQMIG35H2381
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35H2381 |
Region:
Global |
Published Date: January, 2026
Pages:
177
|Tables:
92
|Figures:
71
Global Mice Model Market size was valued at USD 1.71 Billion in 2024 and is poised to grow from USD 1.82 Billion in 2025 to USD 3.03 Billion by 2033, growing at a CAGR of 6.6% during the forecast period (2026–2033).
A major driver of the Global Mice Model Market is the escalating prevalence of chronic diseases, including cancer, diabetes, and cardiovascular disorders. With healthcare systems worldwide prioritizing early diagnosis and treatment innovation, pharmaceutical and biotech companies increasingly rely on mice as preclinical testing models. Their genetic, biological, and behavioural similarities to humans make them indispensable for understanding disease progression and evaluating the safety and efficacy of potential therapies. This rising burden of chronic illnesses fuels greater investments in research and development, thereby directly boosting the demand for advanced mice models to accelerate novel drug discovery and treatment solutions.
A key trend driving the global mice model sector is the rapid advancement of genetic engineering tools, particularly CRISPR-Cas9 technology. These innovations allow researchers to create transgenic, knockout, and humanized mice with high precision, enabling the study of complex human diseases at the molecular level. By replicating specific genetic mutations or humanized immune systems, these models improve the accuracy of preclinical testing, reducing trial failures and speeding up therapeutic development. As pharmaceutical and academic institutions seek more predictive and customizable models, the adoption of genetically engineered mice continues to expand, solidifying their role as indispensable tools in biomedical research.
In What Ways does AI Help Identify Patterns in Disease Progression and Drug Response?
Artificial Intelligence (AI) is reshaping the global mice model market by enhancing the efficiency and precision of preclinical research. AI-powered algorithms can analyze vast datasets from mouse studies, identifying patterns in disease progression, and drug response that would be difficult to detect manually. This accelerates drug development pipelines by reducing trial-and-error experiments and improving translational outcomes. Moreover, AI-driven imaging and behavioral analysis tools allow non-invasive, real-time monitoring of mice, minimizing variability, and enhancing reproducibility. For instance, companies are integrating AI-based digital pathology to evaluate tissue samples more accurately, directly improving the predictive value of mice models in biomedical research.
In February 2025, Harbour BioMed partnered with Insilico Medicine to apply AI for accelerated antibody discovery. This collaboration directly impacts mice model research, as AI-predicted antibodies undergo validation in preclinical mouse studies, reducing experimental failures, optimizing drug pipelines, and strengthening the role of mice models in therapeutic development.
Market snapshot - 2026-2033
Global Market Size
USD 1.6 billion
Largest Segment
CRISPR/CAS9
Fastest Growth
Microinjection
Growth Rate
6.6% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Mice Model Market is segmented by Model Type, Technology, Application, End-User and region. Based on Model Type, the market is segmented into Inbred Mice, Outbred Mice, Genetically Engineered Mice (GEM) and Hybrid / Congenic Mice. Based on Technology, the market is segmented into CRISPR / Gene-Editing, Embryonic Stem Cell Injection, Microinjection / Nuclear Transfer and Traditional Breeding & Rederivation. Based on Application, the market is segmented into Drug Discovery & Development, Disease Modeling (Oncology, Immunology, Neurology, Metabolic), Toxicology & Safety Pharmacology and Personalized / Translational Research. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organisations (CROs) and Government & Regulatory Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
CRISPR/Cas9 technology is dominating the global mice model market by enabling precise and efficient genetic modifications, allowing researchers to create transgenic, knockout, and humanized mice with unprecedented accuracy. Its simplicity, cost-effectiveness, and ability to replicate human disease mutations make it the preferred tool over older gene-editing methods. This dominance stems from its speed in generating customized models, improving disease research, and accelerating drug discovery, thereby solidifying CRISPR/Cas9 as the leading technology in mice model development.
Microinjection technology is projected to be the fastest growing in the global mice model market due to its precision in directly delivering genetic material into mouse embryos. This method ensures stable gene integration, making it highly effective for creating transgenic models. Rising demand for targeted disease research further accelerates its adoption.
Drug discovery & development is the leading application in the global mice model market, driven by rising demand for safer, more effective therapeutics. Mice models are extensively used to evaluate drug efficacy, toxicity, and pharmacokinetics before clinical trials. Current innovations, including humanized mice and advanced imaging, enhance translational accuracy. This dominance is due to pharmaceutical companies’ heavy investment in R&D, where reliable preclinical validation using mice significantly reduces failure rates and accelerates drug pipelines.
Research applications are expected to be the fastest growing segment in the global mice model market due to increasing academic and institutional focus on studying complex diseases and genetic mechanisms. Advances in gene-editing tools like CRISPR/Cas9 are driving demand for customized models, enabling deeper biological insights and fostering innovation across biomedical research.
To get detailed segments analysis, Request a Free Sample Report
North America dominates the global mice model market, supported by its strong biomedical research infrastructure, high R&D investments, and presence of leading pharmaceutical and biotech companies. The region benefits from advanced genetic engineering capabilities, widespread adoption of CRISPR technology, and supportive government funding for disease research. Additionally, rising incidences of chronic conditions fuel demand for preclinical testing. This combination of innovation, resources, and healthcare needs ensures North America’s continued leadership in the mice model market.
The United States is the primary contributor to North America’s mice model market, driven by its robust pharmaceutical and biotechnology sectors, advanced research facilities, and high R&D expenditure. Widespread adoption of CRISPR/Cas9 and transgenic mouse technologies enables precise disease modeling, supporting drug discovery and preclinical testing. Government initiatives and funding for chronic disease and cancer research further boost demand for mice models, making the U.S. a global leader in this market.
Canada contributes significantly to North America’s mice model market through its strong academic research ecosystem and growing biotech industry. Investments in genetic engineering, transgenic mice, and humanized models support advanced disease studies and therapeutic development. Collaborative programs with U.S. institutions and government-backed funding for preclinical research enhance the adoption of mice models, enabling Canada to play a strategic role in North America’s biomedical research and drug development landscape.
Europe holds a significant share in the global mice model market, driven by well-established pharmaceutical and biotechnology industries across countries like Germany, the UK, and France. Strong focus on preclinical research, growing adoption of CRISPR/Cas9 and transgenic models, and supportive regulatory frameworks for fuel market growth. Rising investments in cancer, neurological, and genetic disorder studies further boost demand, positioning Europe as a key hub for advanced mice model research and innovation.
Germany is a leading contributor to Europe’s mice model market due to its advanced pharmaceutical and biotechnology sectors, extensive preclinical research infrastructure, and strong government support for biomedical innovation. High adoption of CRISPR and transgenic mouse technologies accelerates disease modeling for cancer, neurological, and genetic disorders. Collaborative research initiatives with academic and industrial institutions further enhance Germany’s role, making it a pivotal hub for mice model development and drug discovery in Europe.
France plays a key role in Europe’s mice model market, supported by its robust academic research institutions and pharmaceutical industry. The country emphasizes transgenic and humanized mice for preclinical studies, particularly in oncology and immunology. Government-backed funding and initiatives promoting advanced genetic research drive adoption, while collaborations between universities and biotech firms strengthen innovation, positioning France as a significant contributor to the development and utilization of mice models in Europe.
The United Kingdom contributes substantially to Europe’s mice model market through its world-class research universities, biotech clusters, and strong pharmaceutical sector. Focused investment in CRISPR-based and genetically engineered mice enables accurate disease modeling and drug testing. Government grants and initiatives supporting biomedical research, alongside collaborations with global pharmaceutical companies, drive market growth, establishing the UK as a leading hub for mice model innovation, particularly in oncology, neurological, and immunological research.
The Asia Pacific region is witnessing steady growth in the global mice model market, driven by expanding pharmaceutical and biotechnology industries in countries like China, Japan, and India. Increasing R&D investments, rising prevalence of chronic diseases, and growing adoption of CRISPR and transgenic mice technologies for fuel demand. Supportive government initiatives, collaborations with global research organizations, and a focus on drug discovery and preclinical testing position Asia Pacific as a fast-emerging hub in the mice model market.
Japan is a major contributor to the Asia Pacific mice model market, driven by its advanced pharmaceutical and biotechnology sectors and strong focus on preclinical research. High adoption of transgenic, humanized, and CRISPR-engineered mice supports studies in oncology, neurological, and metabolic disorders. Government-backed research funding and collaborations with global pharmaceutical companies enhance innovation, enabling Japan to maintain a leading position in developing accurate and reliable mice models for drug discovery and biomedical research.
South Korea significantly contributes to the Asia Pacific mice model market through its rapidly growing biotech and pharmaceutical industries. Emphasis on genetically engineered mice, including knockout and humanized models, supports advanced disease modeling and therapeutic development. Strong government support, increasing R&D investments, and partnerships with international research organizations accelerate preclinical studies. These factors position South Korea as a key player in advancing mice model applications for drug discovery and biomedical research in the region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Prevalence of Chronic Diseases
Advancements in Genetic Engineering Technologies
High Research and Maintenance Costs
Ethical and Regulatory Concerns
Request Free Customization of this report to help us to meet your business objectives.
The global mice model market outlook is highly competitive, dominated by international players like Charles River Laboratories, Envigo (Inotiv), The Jackson Laboratory, Taconic Biosciences, and Crown Bioscience. Companies focus on strategies such as expanding genetically engineered and humanized mice portfolios, forming strategic collaborations with pharmaceutical firms, and investing in advanced research facilities. For instance, Charles River emphasizes global expansion and AI-driven preclinical services, while The Jackson Laboratory prioritizes developing disease-specific transgenic models to strengthen market leadership.
As per the global mice model market analysis, the market is witnessing rapid innovation from startups leveraging advanced genetic engineering, CRISPR/Cas9, and AI-driven preclinical tools. These emerging companies focus on developing transgenic, knockout, and humanized mice for precise disease modelling. By offering customizable, ethically compliant, and scalable solutions, startups accelerate drug discovery, reduce preclinical failures, and enhance translational research. Their innovations are reshaping preclinical testing, making mice models more predictive, versatile, and relevant to modern biomedical research.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global mice model industry is witnessing substantial growth, driven primarily by the rising prevalence of chronic diseases and advancements in genetic engineering technologies like CRISPR/Cas9. These models provide precise insights into disease mechanisms, enabling safer, faster, and more effective drug discovery. Integration of AI in preclinical research further enhances efficiency, accuracy, and reproducibility, while innovations in microinjection and humanized models support complex disease studies.
Regional leadership in North America, Europe, and Asia-Pacific is fueled by strong R&D investments, advanced infrastructure, and government initiatives. Increasing adoption in drug discovery, research, and translational applications, alongside ethical and sustainable practices, position the global mice model market strategies as indispensable tools, solidifying their role in accelerating global biomedical research and therapeutic development.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 1.71 Billion |
| Market size value in 2033 | USD 3.03 Billion |
| Growth Rate | 6.6% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Mice Model Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Mice Model Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Mice Model Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Mice Model Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
